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Abstract: The host immune response and virus-encoded immune evasion proteins pose constant, 
mutual selective pressure on each other. Virally encoded immune evasion proteins also indicate 
which host pathways must be inhibited to allow for viral replication. Here, we show that IIV-6 is 
capable of inhibiting the two Drosophila NF-κB signaling pathways, Imd and Toll. Antimicrobial 
peptide (AMP) gene induction downstream of either pathway is suppressed when cells infected 
with IIV-6 are also stimulated with Toll or Imd ligands. We find that cleavage of both Imd and 
Relish, as well as Relish nuclear translocation, three key points in Imd signal transduction, occur in 
IIV-6 infected cells, indicating that the mechanism of viral inhibition is farther downstream, at the 
level of Relish promoter binding or transcriptional activation. Additionally, flies co-infected with 
both IIV-6 and the Gram-negative bacterium, Erwinia carotovora carotovora, succumb to infection 
more rapidly than flies singly infected with either the virus or the bacterium. These findings 
demonstrate how pre-existing infections can have a dramatic and negative effect on secondary 
infections, and establish a Drosophila model to study confection susceptibility. 
Keywords: viral immune evasion; immunomodulators; NF-κB; Imd; DNA virus; host-pathogen 
interactions; IIV-6 
 
1. Introduction 
The host immune system and the viruses that challenge it face constant, mutual, selective 
pressure for survival. This perpetual arms race, known as the Red Queen Hypothesis [1], has created 
a plethora of mechanisms that the cell uses to thwart viral replication, and also a plethora of novel 
immune evasion tactics that viruses use to evade the immune response, in some cases even stealing 
genes from their hosts to suit this purpose [2]. In order to evade the innate immune response, 
viruses—especially large DNA viruses—encode a variety of immune evasion proteins to facilitate 
their replication. For example, the model poxvirus Vaccinia encodes a variety NF-κB pathway 
inhibitors, and a recently identified invertebrate DNA virus, Kallithea virus, is able to inhibit 
Drosophila Toll signaling [3,4]. Invertebrate Iridescent Virus-6 (IIV-6) is a large DNA virus capable of 
infecting Drosophila [5,6], with an estimated 215 open reading frames (ORFs) [7]. The large genome 
of IIV-6 suggests it encodes for many evasion proteins in addition to the characterized suppressor of 
RNAi (340L) [8], and Inhibitor of Apoptosis Protein (IAP) (193R) [9,10]. The interplay between the 
virus and host, particularly which pathways the virus devotes its resources to inhibit, provides 
insight as to which defense mechanisms pose the most threat to viral replication. A virus devoting 
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its resources to shutting down a particular host pathway indicates that this pathway has applied 
selective pressure against the virus. 
Whether the Toll and Imd pathways play a role in antiviral defense has been a topic probed in 
several studies, often with mixed or conflicting results [11–14]. Of course, these two NF-κB signaling 
pathways are well-known for their roles in anti-bacterial and anti-fungal defense, through the 
regulation of antimicrobial peptides (AMPs) and other effectors[15–18]. While some studies have 
argued these two pathways also have some antiviral activities, the antiviral mechanisms have not 
been elucidated [2,12,19–21]. To address the question of the potential anti-DNA-viral role of the Toll 
and Imd pathways, we took the approach of using the virus to illuminate which pathways might be 
antiviral by examining whether IIV-6 inhibits the Toll and Imd pathways. We found that cells infected 
with IIV-6 have suppressed AMP production, while other immune genes (i.e., Turandots, c-Jun N-
terminal kinase (JNK) targets) remain induced, suggesting that this is not a global suppression of host 
transcription [22]. Surprisingly, the cleavage of both Imd and Relish, key signaling events in the Imd 
pathway [23,24], remain intact in IIV-6 infected cells. Relish nuclear translocation is also at least partly 
intact, indicating the blockage in Imd response likely occurs in the nucleus, at the level of promoter 
binding or transcriptional activation. The inhibition of NF-κB transcription factor activity may be 
more general, as the Toll pathway was also blocked by IIV-6 infection. Consistent with the inhibition 
of these critical antibacterial defense responses, flies infected with IIV-6 were hyper-susceptible to 
infection with the Gram-negative bacteria Erwinia carotovora carotovora (Ecc15), establishing a system 
for studying co-infection morbidity in the Drosophila model. 
2. Materials and Methods 
2.1. RNA Isolation and qRT-PCR 
Total RNA from flies or S2* cells was extracted using TRIzol (Invitrogen, Waltham, MA, USA). 
Samples were then DNase treated (RQ1, Promega, Madison, WI, USA) and RNA re-extracted by 
phenol-chloroform. The cDNA was synthesized using iScript cDNA Synthesis kit (BioRad, Hercules 
CA, USA). Alternatively, the gDNAclear cDNA synthesis kit (BioRad) was used following TRIzol 
purification. The quantitative reverse transcriptase–polymerase chain reaction (qRT-PCR) was 
analyzed by normalizing to the housekeeping gene Rp49. 
2.2. The nCounter Analysis 
The expression levels of 102 Drosophila immune genes (Supplemental Table S1,2) were assayed 
from 100 nanograms of RNA via a customized Nanostring nCounter codeset. Two biological 
replicates of S2* cells were analyzed for each treatment and timepoint. The results were analyzed 
using nSolver 4.0 software according to the manufacturer’s instructions (NanoString Technologies, 
Seattle, WA, USA), and the heatmap was created using nSolver 4.0 software and JavaTree. Shown are 
the AMPs, p38, JNK, and JAK-STAT targets with counts above background. Figure 3 analyzes data 
previously presented in West et al. [22]. 
2.3. Fly Stocks and In Vivo Studies 
Three to five day old w1118 flies, of approximately equal proportions male and female, maintained 
at 22 °C, were used for all experiments. Flies were injected intrathoracically with 32.2 nL of virus (1 × 
104 TCID50) or vehicle (PBS) using a Nanoject II (Drummond, Broomall, PA, USA). For survival 
assays, a minimum of fifty flies were used per treatment, per genotype, and the dead were counted 
daily. Kaplan-Meier curves are shown and significance was determined by Mantel-Cox log-rank 
using GraphPad Prism. 
Erwinia carotovora carotovora 15, also known as Pectobacterium carotovora, was cultured overnight 
by shaking at 250 RPMs in LB broth, pelleted at 13,000× g for 10 minutes in a microfuge, washed in 
PBS, and re-pelleted. Infections were performed by dipping a microsurgery needle into the 
concentrated bacterial pellet, and pricking in the thorax. The IIV-6 injection site was identified using 
melanization, and bacterial pricking was performed on the opposite side of the thorax. 
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2.4. Cell Culture 
S2* cells were cultured as previously described [25,26] and were treated with 1 μM 20-
hydroxyecdysone, (EcD) for 18 h followed by infection with IIV-6 at a multiplicity of infection (MOI) 
of 2 for 6 h. Cells were then stimulated with 2 μg/mL PGN for 6 h to stimulate the Imd pathway, or 
stimulated with cleaved Spätzle for 18 h for Toll pathway stimulations, and were harvested for RNA 
isolation.  
2.5. Immunoblots 
S2* cells were cultured and treated as described above. For protein analysis, cells were then 
stimulated with 2 μg/mL PGN for 15 min to stimulate the Imd pathway, and harvested in lysis buffer 
consisting of 1% Triton X-100, 20 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, and 10% glycerol, 
with 1 mM DTT, 1 mM Sodium Vandate, 20 mM β-glycerolphosphate, and protease inhibitors. Imd 
or c-Rel antibodies were used as previously described [24,27]. 
2.6. Confocal Microscopy 
YFP-Relish over-expressing cells were kept in selection media with hygromycin (200 μg/mL), 
and cultured as previously described [28]. Cells were treated with EcD for 2 h before being infected 
with mCherry-IIV-6 at an MOI of 2 for 18 h. Cells were then plated on Alcian Blue or ConA treated 
coverslips for 30 min and stimulated with PGN for 15 min. Cells were fixed in 4% paraformaldehyde, 
and stained with anti-lamin Dm0 (Developmental Studies Hybridoma Bank, ADL84.12) and Hoechst 
33342. 
2.7. Virus Preparation 
IIV-6 was provided by Luis Teixeira. IIV-6 was propagated and purified on DL-1 cells as 
previously described [5], with a final resuspension in PBS, and quantified on DL-1 cells by TCID50. 
Cells were infected at an MOI of 2 unless otherwise noted, while flies were injected with 1 × 104 
TCID50, as detailed above. 
The ΔTS-MCP-mCherry-IIV-6 (mCherry-IIV-6) was created by inserting mCherry under the 
control of the major capsid promoter into the thymidylate synthase locus, using homologous 
recombination [29]. The major capsid promoter sequence was designed based on the analysis of IIV-
6 MCP regulatory sequences by Nalçacioǧlu et al. [30]  
3. Results 
3.1. AMP Production is Suppressed in the Presence of IIV-6 
Given the scarce and somewhat conflicting data on the antiviral effects of the Drosophila NF-κB 
pathways in response to viral infections [2,12,19–21], we tested whether IIV-6 inhibits the Imd or Toll 
pathways. S2* cells were differentiated with 1 μM 20-hydroxyecdysone (EcD) for 18 h followed by 
IIV-6 infection for 6 h. Treatment with EcD is required to differentiate these cells and induce the 
expression of the receptor PGRP-LC, making these cells highly responsive to DAP-type 
peptidoglycan (PGN) stimulation [28]. After 6 h of IIV-6 infection, cells were then stimulated with 2 
μg/mL of PGN for an additional 6 h, and gene expression analyzed by qRT-PCR. IIV-6 infection 
reduced transcriptional induction of the Imd-dependent AMP gene Diptericin to near background 
levels (Figure 1A). 
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Figure 1. IIV-6 inhibits Imd and Toll Signaling. (A) S2* cells were treated with 20-hydroxyecdysone 
(EcD) as indicated for 18 hours and then infected with IIV-6 (blue circles) or uninfected (black circles) 
for six hours. Cells were then stimulated with DAP-type PGN for six hours, where indicated. 
Diptericin (Dpt) levels were monitored by qRT-PCR. (B) S2* cells were treated with 20-
hydroxyecdysone (EcD) as indicated for 18 h and then infected with IIV-6 (blue circles) or uninfected 
(black circles) for six hours. Cells were then stimulated with cleaved Spätzle (spz) for 18 h, where 
indicated. Drosomycin (Drs) levels were monitored by qRT-PCR. (A,B) Black bars indicate mean and 
error bars indicate standard deviation. Statistics were determined using two-way ANOVA and 
Sidak’s multiple comparisons test; ns, not significant; ****, p < 0.0001. 
To determine if IIV-6 more generally blocks NF-κB signaling, we similarly analyzed Toll 
signaling. S2* cells were cultured in a similar manner, treated with EcD for 18 h, which upregulates 
expression of the Toll receptor [28], infected with IIV-6 for 6 h, and then stimulated with the Toll 
ligand, cleaved Spätzle, for 18 h. Induction of the Toll target gene Drosomycin was strongly inhibited 
by IIV-6 infection, as analyzed by qRT-PCR (Figure 1B). To examine both of these NF-κB pathways 
more broadly, we utilized NanoString nCounter Analysis, with a custom designed codeset probing 
over 100 immune-related genes, including most known AMP genes. All of the antimicrobial peptides 
were down-regulated in IIV-6 infected samples when the Imd pathway was stimulated with PGN 
(Figure 2A, Supplemental Table S1) or Toll pathway stimulated with cleaved Späztzle (Figure 2B, 
Supplemental Table S2), compared to the mock-infected controls stimulated with Imd or Toll ligands. 
Notably, other groups of genes were induced by virus infection, including the JNK targets puckered 
and punch, and the p38-dependent genes upd3 and Ddc [22,31]. The antiviral gene Ars2 was also 
induced by IIV-6 [32]. Since JNK signaling can be initiated through TAK1, the fact that JNK targets 
are being transcribed suggests that Imd signaling is being initiated, and signaling successfully occurs 
through at least TAK1 [33]. The induction of these genes by IIV-6 argues that the virus is not simply 
shutting down all host transcription, but is specifically targeting the two NF-κB signaling pathways, 
Imd and Toll. Additionally, we saw no suppression of GAPDH1 levels (Supplemental Figure S1). 
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Figure 2. Both Imd and Toll regulated AMPs are suppressed by IIV-6 infection. S2* cells were treated 
with 20-hydroxyecdysone (EcD) for 18 h, and then infected with IIV-6 for 6 h. (A) Cells were 
stimulated with peptidoglycan (PGN) for 6 h prior to RNA isolation. (B) S2* cells were then stimulated 
with cleaved Spätzle (spz) for 18 h prior to RNA isolation, and then analyzed by Nanostring 
nCounter. Heatmaps display Z scores of mRNA levels of immune genes in the presence or absence 
of virus and pathway stimulation clustered by expression pattern. Biologically independent 
duplicates are shown. Untr., untreated cells. EcD, cells treated with 20-hydroxyecdysone. EcD + PGN, 
cells treated with 20-hydroxyecdysone and peptidoglycan. EcD + spz, cells treated with 20-
hydroxyecdysone and Spätzle. 
IIV-6 inhibition of both NF-κB pathways suggests that these pathways may function to limit 
viral replication. To examine this possibility, we analyzed an earlier Nanostring dataset from adult 
flies infected with IIV-6, or injected with a similar volume of PBS, to determine if virus infection 
induces any of the AMP genes [22]. Indeed, IIV-6 modestly induced AMP gene expression two-fold 
over PBS-injected controls 12 hours post-infection (Figure 3A,A’). However, by 24 h, this induction 
has returned to, or in some instances below, baseline levels. These findings are consistent with an 
early AMP response, possibly through NF-κB signaling pathways, which is quickly extinguished by 
viral inhibitors. 
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Figure 3. Some AMPs are elevated in vivo upon IIV-6 infection, before returning to baseline. (A) 
Heatmap of Z score transformed mRNA levels for AMP genes following IIV-6 infection of adult male 
w1118 flies for the indicated timepoints, assayed by Nanostring nCounter. RNA was isolated from PBS-
injected flies at the same time points as a control. Biologically independent samples were analyzed in 
duplicate. (A’) Detailed comparison of mRNA levels for selected Imd-regulated AMP genes following 
IIV-6 infection of adult w1118 flies for 12, 24, and 48 h assayed by Nanostring nCounter. 
3.2. NF-κB Inhibition is Downstream of Imd and Relish 
Next, we focused on the Imd pathway to tease apart the mechanism of NF-κB inhibition by IIV-
6. As Imd signaling requires cleavage of Imd by the caspase 8-like Dredd [24,34], we probed for 
cleaved Imd in IIV-6 infected or uninfected cell lysates. We found robust cleavage of Imd upon PGN 
stimulation in both the presence and absence of IIV-6, indicating that the blockage of Imd signaling 
is likely to occur downstream of Imd cleavage (Figure 4A). To probe further downstream, we 
examined Relish cleavage, another critical event in Imd signaling, utilizing a C-terminal Relish 
antibody. As expected, samples mock treated or infected with IIV-6 alone show a prominent 110 kD 
band indicating full-length Relish, and control samples treated with EcD and PGN show complete 
processing of full-length Relish. Likewise, upon PGN stimulation, Relish was fully cleaved in the 
presence of IIV-6, even at a relatively high MOI (Figure 4B, lanes 4–6). These results indicate the 
inhibition of Imd signaling by IIV-6 occurs downstream of Relish cleavage, the key event in the 
activation of this NF-κB precursor. 
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Figure 4. Imd signaling remains intact in the presence of IIV-6. (A) S2* cells were treated with 20-
hydroxyecdysone (EcD) for 18 h. Cells were then infected with IIV-6, where indicated, for six hours. 
Samples were then stimulated with PGN for 15 min, where indicated, and lysed in standard lysis 
buffer. Endogenous Imd was monitored by immunoblotting; arrows indicate cleaved (c-Imd) or full-
length (FL-Imd) Imd; ns, non-specific. (B) Cells were treated with 20-hydroxyecdysone (EcD), where 
indicated, for 18 h and infected with IIV-6, as indicated, for six hours. Samples stimulated with EcD 
were then stimulated with PGN for 15 min, and lysed in standard lysis buffer. Endogenous Relish 
was probed by immunoblotting using a C-terminal Relish antibody. MOI used was as follows. Lane 
2: MOI =2; Lane 4: MOI = 0.2; Lane 5: MOI = 2; Lane 6: MOI = 5. 
Since Relish is cleaved in the presence of IIV-6, we next sought to determine whether IIV-6 
inhibits Imd signaling through blocking Relish nuclear translocation. To this end, we utilized a YFP-
Relish over-expressing cell line, and a strain of IIV-6 expressing mCherry under the control of the 
major capsid protein (MCP). Even with these tools, scoring Relish nuclear translocation after virus 
infection presented several technical challenges. In particular, viral infected cells adhered poorly to 
treated coverslips and displayed reduced YFP-Relish signal. However, the levels of endogenous 
Relish protein are not altered by IIV-6 infection (Figure 4B). Additionally, IIV-6 undergoes massive 
DNA viral replication in the cytoplasmic viral factories, making it difficult to distinguish the nucleus. 
In order to identify the nucleus, cells were stained with both Hoechst 33342 and the nuclear envelope 
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marker Lamin to accurately discern the nucleus from the cytosolic viral factory. In control conditions, 
cells stimulated with PGN showed 35% nuclear translocation, while Relish remained cytoplasmic in 
20% of cells (Figure 5A, lower left panel, Figure 5B). The remaining 44% of cells contained a YFP 
signal in both the cytoplasm and nucleus or had a YFP signal too weak to determine localization. In 
IIV-6 infected cells, we found that approximately 17% showed nuclear translocation, with 33% 
remaining cytoplasmic, while nearly 50% displayed both cytoplasmic and nuclear Relish or had a 
YFP signal too weak to determine localization (Figure 5A lower right panel, Figure 5B). While IIV-6 
reduces the detected level of PGN-induced Relish nuclear translocation compared to uninfected 
PGN-stimulated cells, this difference was not significant, suggesting PGN can still trigger some 
Relish nuclear translocation in virus infected cells. Interestingly, virus infection alone caused some 
Relish translocation (Figure 5A upper right panel, Figure 5B). These data suggest that IIV-6 does not 
completely inhibit Relish nuclear translocation, and that viral suppression of Imd signaling likely 
occurs downstream, either at the level of Relish promoter binding or transcriptional activation. 
 
Figure 5. Nuclear localization of Relish remains intact in the presence of IIV-6. (A) S2* cells stably 
expressing YFP-Relish were treated with 20-hydroxyecdysone (EcD) for 2 h and then infected with 
mCherry-IIV-6 (right) or left uninfected (left) for 18 h. Cells were then stimulated with DAP-type PGN 
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for 15 min (lower panels), prior to fixation and staining with anti-Lamin (shown in green) and Hoechst 
33342 (shown in blue). Representative images from four biologically independent experiments are 
shown. Arrowheads mark cells with nuclear localized Relish. Left panels display the overlay of YFP-
Relish, Hoeschst, Lamin, and mCherry-IIV-6 where applicable, while the right panels exhibit the YFP-
Relish alone. Scale bars are 10 μm. (B) Quantification of Relish nuclear translocation. Between 400–
1800 cells were scored for each condition as displaying Relish localization in the nucleus, in the 
cytoplasm, or as indeterminate when staining was diffuse throughout both compartments or the 
signal was too weak to discern. Statistics were determined using two-way ANOVA and Tukey’s 
multiple comparisons test; *, p < 0.05; ns, not significant. Error bars represent standard deviation. 
3.3. Inhibition of NF-κB Signaling is Mediated by an Immediate Early Gene 
Most—but not all—immune evasion proteins are immediate early genes. Strategically, it is 
probably most effective, from the virus perspective, to shut down the host defense as quickly as 
possible and rapidly achieve high levels of replication. In order to determine if IIV6 inhibition of 
Drosophila NF-κB signaling also involves an early gene product, cells were treated with the viral 
polymerase inhibitor cidofovir, or infected with heat- or UV-inactivated virus, and then stimulated 
with PGN to probe Imd signaling. PGN-triggered Diptericin induction was blocked with all three 
virus-inactivating treatments (Figure 6), indicating that the IIV6-mediated NF-κB inhibition was the 
result of immediate early genes, or possibly associated with a factor directly delivered with the virion. 
 
Figure 6. Viral replication is not needed for NF-κB inhibition. (A,B) S2* cells were treated with 20-
hydroxyecdysone (EcD) as indicated for 18 h and then infected with IIV-6 (blue circles) or uninfected 
(black circles) for six hours. Cells were then stimulated with DAP-type PGN for six hours, where 
indicated. Diptericin levels were monitored by qRT-PCR. (A) Cells were treated with cidofovir, a viral 
polymerase inhibitor, where indicated. Mock cells untreated with EcD, PGN, or cidofovir are shown 
as a control. Each data point is a biologically independent replicate; n = 3. Error bars represent 
standard deviation. Statistics were determined using two-way ANOVA and Sidak’s multiple 
comparisons test; ns, not significant; ****, p < 0.0001. (B) S2* cells were infected with IIV-6 (blue circles), 
or treated with UV- (purple circles) or heat- (red circles) inactivated IIV-6. Uninfected controls are 
shown in black. Each data point is a biologically independent replicate; n = 3. Error bars represent 
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standard deviation. Statistics were determined using one-way ANOVA and Tukey’s multiple 
comparisons test; ns, not significant; ***, p < 0.001. 
3.4. Flies Infected with IIV-6 are more Susceptible to Bacterial Infection 
Together, these results indicate that infection with IIV-6 results in the global suppression of NF-
κB signaling in flies—a major component of the innate immune response to bacterial and fungal 
infections in flies and mammals. Consistent with our in vitro data showing universally suppressed 
AMPs, we found that flies infected with IIV-6 also had suppression of NF-κB signaling, as indicated 
by lower mRNA levels of the AMP genes Diptericin and Drosomycin compared to PBS-injected or 
unmanipulated flies at day 8 post-infection (Figure 7A, Supplemental Figure S2). This suggests that 
flies infected with IIV-6 should be highly susceptible to other microbial infections. To test this 
hypothesis, we infected Drosophila adults with IIV-6 for seven days. On day eight post-IIV-6 infection, 
we pricked one group with a sterile needle, and the other group of flies with a needle dipped in 
Erwinia carotovora carotovora (Ecc15), a Gram-negative pathogen with limited lethality in healthy, 
immunocompetent flies. Seven days after this secondary bacterial infection, 50% of the flies infected 
with both IIV-6 and Ecc15 had succumbed to infection, with nearly 100% lethality by day 20 (Figure 
7B). In contrast, flies that had been mock-injected with PBS prior to Ecc15 infection had a median 
survival time of twenty-three days post-secondary (bacterial) infection. The animals injected with 
IIV-6 followed by a clean prick reached 50% lethality only at day 18, typical of the IIV-6 survival 
curve [22]. Together, these data show that an underlying IIV-6 infection can have a dramatic effect 
on a secondary bacterial infection, causing flies to be far more susceptible to Ecc15 infection than 
unaffected animals. Given the critical role of the Imd pathway in defending against Ecc15 infection, 
these results are consistent with the inhibition of Imd signaling observed in IIV-6 infected S2* cells 
and adult flies. 
 
Figure 7. Flies infected with IIV-6 have lower AMP levels. (A) Adult w1118 flies were infected with IIV-
6, injected with PBS, or left unmanipulated for 7 days, and then snap frozen for RNA isolation. Dpt 
levels were assayed by qRT-PCR. Black bars indicate mean and error bars indicate standard deviation. 
Statistics were determined using one-way ANOVA and Tukey’s multiple comparisons test; ns, not 
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significant; *, p = 0.0463; **, p = 0.0033. (B) Kaplan-Meier plots of adult w1118 flies infected with IIV-6 
(blue lines) or PBS-injected (black lines) for 8 days prior to bacterial infection. On day 0, flies were 
pricked with Ecc15 (solid lines) or were sterile pricked (dashed lines) with a microsurgery needle. 
Flies were counted daily for survivors. Statistics were determined using log-rank test; ****, p < 0.0001. 
4. Discussion 
Here, we show that IIV-6 infection interferes with the antimicrobial peptide response mediated 
through the Toll and Imd NF-κB pathways. In addition, we find that flies infected with IIV-6 succumb 
to an otherwise mildly pathogenic bacterial infection in vivo. Together, our data show that an 
underlying infection with this DNA virus can dampen the immune response and dramatically alter 
the outcome of a secondary bacterial infection, turning an otherwise innocuous infection into a lethal 
one. 
While it appears that IIV-6 is suppressing the AMP response by actively inhibiting the NF-κB 
pathways, the mechanisms of inhibition remain unclear. It is possible that IIV-6 encodes an NF-κB 
inhibitor that prevents Relish binding to κB sites or recruitment of polymerase machinery. Several 
examples of viral-encoded NF-κB inhibitory proteins acting within the nucleus have been reported. 
NF-κB inhibitors functioning within the nucleus are encoded by vaccinia virus (VACV) [35], as well 
as African swine fever virus A238L [36]. VACV also encodes an inhibitor of Type 1 IFN, C6, that 
functions post-STAT1 and 2 nuclear translocation and DNA binding by binding the STAT2 
transactivation domain [37]. Another VACV protein, N2 inhibits IRF3 within the nucleus [38]. Future 
studies will be aimed at examining the effect of IIV-6 on Relish binding at AMP gene κB sites, as well 
as the transcriptional activation process.  
The timing of suppression also needs to be examined more closely. While our in vivo or in vitro 
data may suggest a difference in the suppressive effects of IIV-6, it is important to note that a more 
detailed in vivo time course is required. If there is a true shift in suppression, we hypothesize that 
this may be due to the fact that the in vitro infections occur at an MOI of 2, and we can more easily 
synchronize the timing of infection. In vivo, it may be that virus takes longer to diffuse through the 
hemolymph and replicate, resulting in a difference in response. 
It should be noted that IIV-6 does not encode a homolog of Diedel, the putative Imd inhibitor, 
as other large insect DNA viruses do [2]. Given the role of RHIM-dependent amyloid fibrils in the 
Imd pathway [39], we also considered that IIV-6 might encode RHIM-inhibitor, similar to Murine 
cytomegalovirus M45 [40], but found no evidence for such a factor in the IIV-6 genome. 
Future studies will be required to determine which viral gene(s) are responsible for NF-κB 
inhibition. Our work shows that Imd signaling is inhibited at a step downstream of Relish activation. 
However, the mechanisms of Toll inhibition have not been investigated yet. IIV-6 may encode more 
than one NF-κB inhibitor, targeting the Imd and Toll pathways at different points. Since other large 
DNA viruses, such as VACV, encode multiple inhibitors targeting NF-κB pathways at various points 
in mammalian NF-κB signaling pathways [3], elimination of single viral genes may not reveal any 
phenotype due to redundancies. Determining which viral genes are responsible for NF-κB inhibition 
will require both loss and gain of function approaches and will be the subject of future studies.  
IIV-6 has a broad host range, infecting a large variety of insects with agricultural and economic 
importance. The slow replication cycle of this virus results in infected insects surviving for weeks, 
allowing it to spread amongst a population, and consequently, leaving that population with an 
increased susceptibility to a secondary bacterial infection that would otherwise be cleared. Given the 
current decline of honey bees, as well as the entire insect population [41], a persistent viral infection 
could further damage this already precarious population by increasing susceptibility to a range of 
other microbial pathogens. While previous studies have ruled out IIV-6 as the causative agent of 
colony collapse disorder [42], it should be noted that IIV-6 infection may expose other species to 
increased vulnerability to a secondary infection.  
In summary, we have shown that IIV-6 infection results in an inability to mount an NF-κB 
mediated AMP response upon stimulation of either the Imd or Toll pathways. It appears that IIV-6 
infection may briefly induce AMP expression before shutting it down. Suppression of Imd signaling 
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occurs downstream of Relish activation, suggesting a viral inhibitor may act at the level of DNA 
binding and transcriptional activation. Nanostring data showing that IIV-6 induces transcription of 
JNK targets suggest that the Imd pathway is being successfully activated through at least the branch 
point of TAK1 [25]. These results are consistent with the data showing that Relish cleavage and some 
nuclear translocation remain intact and argue that the virally generated block occurs far downstream 
in this pathway. Strikingly, flies infected with IIV-6 subjected to subsequent infection with Ecc15 died 
more rapidly than flies singly infected with virus or bacteria, indicating that this virus-mediated 
block in NF-κB signaling may have a profound effect on resistance to bacterial infections.  
The involvement of the Drosophila NF-κB pathways in antiviral signaling is a controversial 
topic. Other studies have suggested an antiviral role for AMPs, examining a recombinant analog of 
the RNA virus Sindbis virus [21]. Whether or not some AMPs are also potent against DNA viruses, 
such as IIV-6, will be the focus of future studies, for example by examining the replication of mCherry 
-expressing virus or by quantifying viral loads from infected flies over-expressing AMPs. It is also 
possible that AMP induction is simply a by-product of Relish activation, similar to many ISGs that 
have no direct protective role against the pathogen eliciting their expression. In this case, other Relish 
target genes may be important for antiviral defense. Additionally, with some picrorna-like viruses, 
such as Drosophila C virus and Cricket Paralysis virus, some—but not all—Imd pathway 
components seem to be restrictive [12,13]. Identifying a viral-encoded Imd inhibitor would provide 
more evidence supporting that this pathway induces antiviral activities. However, how Imd 
signaling is initiated upon virus infection, when the established agonist for this pathway is bacterial 
peptidoglycan [43,44], and whether all Imd signaling components are necessary, need to be examined 
in greater detail. For example, as the key receptors in this pathway, PGRP-LC and PGRP-LE, directly 
bind to DAP-type PGN, it seems unlikely that they will be involved in viral recognition. Antiviral 
studies implicating Imd signaling should be reevaluated in light of recent work showing that the 
microbiome plays an important role activating Imd signaling in the gut to prime an antiviral response 
via ERK following an oral infection route [45]. Whether commensals can act to influence antiviral 
responses in other organ systems requires further exploration. For example, the Malpighian tubules 
are organs branching off from the Drosophila gut, which absorb waste from the hemolymph, but have 
also been shown to serve important roles in immune function, including induction and secretion of 
AMPs in response to infection [43,46–48]. Whether the Malpighian tubules provide crosstalk between 
the gut and hemolymph during viral infections should be explored. 
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